| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 23 | $7.62 | $175.26 | -0.3% | +31.7% | - | |
| Nov 10, 2025 | BDSX Biodesix Inc | Vazquez Chris65 | Chief Accounting Officer | Sell | 13 | $7.62 | $99.06 | -1.4% | +31.7% | - | |
| Nov 10, 2025 | SHC Sotera Health Co | Warburg Pincus & Co.67 | Director, 10% Owner | Sell | 18,000,000 | $15.65 | $281,718,000.00 | -29.1% | +10.6% | - | |
| Nov 10, 2025 | SHC Sotera Health Co | Gtcr Investment XI LLC74 | Director, 10% Owner | Sell | 12,000,000 | $15.65 | $187,812,000.00 | -29.1% | +10.6% | - | |
| Nov 10, 2025 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 189 | $7.62 | $1,440.18 | -0.5% | +31.7% | - | |
| Nov 10, 2025 | SHC Sotera Health Co | Warburg Pincus & Co.67 | Director, 10% Owner | Sell | 18,000,000 | $15.65 | $281,718,000.00 | -29.1% | +10.6% | - | |
| Nov 10, 2025 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 25 | $7.62 | $190.50 | -0.3% | +31.7% | - | |
| Nov 10, 2025 | TMO Thermo Fisher Scientific Inc. | Pettiti Gianluca63 | Executive Vice President | Sell | 2,975 | $580.00 | $1,725,500.00 | -6.6% | -5.1% | - | |
| Nov 10, 2025 | DHR Danaher Corp /de/ | Couchara Georgeann56 | SVP, Human Resources | Sell | 5,174 | $210.42 | $1,088,703.65 | -45.3% | +2.6% | - | |
| Nov 10, 2025 | MTD Mettler Toledo International Inc/ | Finney Elisha W66 | Director | Sell | 474 | $1,433.57 | $679,512.18 | -60.4% | -3.6% | - | |
| Nov 10, 2025 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 50 | $7.62 | $381.00 | -0.4% | +31.7% | - | |
| Nov 10, 2025 | VCYT Veracyte, Inc. | Wygant Jonathan | VP, Chief Accounting Officer | Sell | 10,920 | $41.20 | $449,907.35 | -11.7% | -13.3% | - | |
| Nov 7, 2025 | BLLN Billiontoone, Inc. | Rai Akshay | Director | Buy | 2,500 | $60.00 | $150,000.00 | +22.7% | -14.9% | - | |
| Nov 7, 2025 | BLLN Billiontoone, Inc. | Ten Bosch John Roderick | See Remarks | Buy | 800 | $60.00 | $48,000.00 | +2.2% | -14.9% | - | |
| Nov 7, 2025 | BLLN Billiontoone, Inc. | Lynch Thomas P. | See Remarks | Buy | 100 | $60.00 | $6,000.00 | +16.7% | -14.9% | - | |
| Nov 7, 2025 | BLLN Billiontoone, Inc. | Johnson Nancy Joann | See Remarks | Buy | 6,900 | $60.00 | $414,000.00 | +23.8% | -14.9% | - | |
| Nov 7, 2025 | GH Guardant Health, Inc. | Saia John G. | Chief Legal Officer | Sell | 8,996 | $96.25 | $865,865.00 | -17.2% | +1.7% | - | |
| Nov 7, 2025 | TMO Thermo Fisher Scientific Inc. | Britt Lisa P.69 | Sr. VP And Chief Hr Officer | Sell | 10,225 | $571.62 | $5,844,850.07 | -26.5% | -5.2% | - | |
| Nov 7, 2025 | CDNA Caredx, Inc. | Novack Jeffrey Adam68 | Secretary And General Counsel | Sell | 2,688 | $15.52 | $41,722.87 | -2.5% | +17.5% | - | |
| Nov 7, 2025 | BLLN Billiontoone, Inc. | Tsao David | Chief Technology Officer | Buy | 1,000 | $60.00 | $60,000.00 | New | -14.9% | - | |
| Nov 7, 2025 | GH Guardant Health, Inc. | Hidalgo Medina Manuel | Director | Sell | 1,500 | $95.19 | $142,780.15 | -41.3% | +1.7% | - | |
| Nov 7, 2025 | BLLN Billiontoone, Inc. | Bremner Thomas S | Director | Buy | 41,666 | $60.00 | $2,499,960.00 | +2.5% | -14.9% | - | |
| Nov 6, 2025 | BIO Bio-Rad Laboratories, Inc. | Barry James | EVP, President, Lsg | Sell | 700 | $306.18 | $214,288.51 | -57.9% | -0.2% | - | |
| Nov 5, 2025 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 43,196 | $45.06 | $1,946,287.73 | -11.8% | -18.0% | - | |
| Nov 5, 2025 | MEDP Medpace Holdings, Inc. | Geiger Jesse J60 | President | Sell | 21,503 | $595.66 | $12,808,476.98 | -58.9% | -5.1% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.